While the small size of RTX-CD47 may be challenged with poor PK [86], the dual targeting strategy in a tandem scFv format allowed select targeting of cancer cells and avoided excessive activation and ADCC due to absence of Fc region. The gene discussed is CD47; the disease is cancer.